Albert Y Liu

Summary

Affiliation: San Francisco General Hospital
Country: USA

Publications

  1. pmc Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California San Francisco UCSF, San Francisco, California, United States of America
    PLoS ONE 9:e83736. 2014
  2. pmc Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco
    Albert Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Med 11:e1001613. 2014
  3. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
  4. ncbi request reprint Preexposure prophylaxis for HIV: unproven promise and potential pitfalls
    Albert Y Liu
    HIV Research Section, San Francisco Department of Public Health, San Francisco, Calif 94102, USA
    JAMA 296:863-5. 2006
  5. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011
  6. pmc Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men
    Julia L Marcus
    Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America University of California, Berkeley, California, United States of America
    PLoS ONE 9:e91513. 2014
  7. ncbi request reprint HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
  8. pmc Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    Robert M Grant
    J David Gladstone Institutes, University of California at San Francisco, 1650 Owens St, San Francisco, CA 94158, USA
    N Engl J Med 363:2587-99. 2010
  9. pmc Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
    Marc M Solomon
    aThe Gladstone Institutes bUniversity of California cBridge HIV, San Francisco Department of Public Health, San Francisco, USA dInvestigaciones Medicas en Salud eAsociación Civil Impacta Salud y Educación, Lima, Peru fInstituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil gFenway Institute, Fenway Health, Boston, USA hResearch Institute for Health Sciences iDepartment of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand jProjeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil kDesmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa lDivision of Clinical Immunology and Allergy, School of Medicine, University of São Paulo mInstituto de Investigação em Imunologia, CEP 05403 900 Cerqueira Cesar, Sao Paulo, Brazil nNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    AIDS 28:851-9. 2014
  10. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013

Detail Information

Publications13

  1. pmc Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California San Francisco UCSF, San Francisco, California, United States of America
    PLoS ONE 9:e83736. 2014
    ..To evaluate the relationship between dose and tenofovir concentrations in hair, we examined the dose proportionality of tenofovir in hair in healthy, HIV-uninfected adults...
  2. pmc Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco
    Albert Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Med 11:e1001613. 2014
    ..Please see later in the article for the Editors' Summary. ..
  3. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
    ..To evaluate for changes in sexual behaviors associated with daily pill use among men who have sex with men (MSM) participating in a preexposure prophylaxis trial...
  4. ncbi request reprint Preexposure prophylaxis for HIV: unproven promise and potential pitfalls
    Albert Y Liu
    HIV Research Section, San Francisco Department of Public Health, San Francisco, Calif 94102, USA
    JAMA 296:863-5. 2006
  5. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011
    ..We determined the baseline prevalence of low bone mineral density (BMD) and the effect of TDF on BMD in men who have sex with men (MSM) in a PrEP trial in San Francisco...
  6. pmc Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men
    Julia L Marcus
    Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America University of California, Berkeley, California, United States of America
    PLoS ONE 9:e91513. 2014
    ..We examined the effect of daily oral emtricitabine/tenofovir (FTC/TDF) PrEP on HSV-2 seroincidence and ulcer occurrence among men who have sex with men (MSM) in the iPrEx trial...
  7. ncbi request reprint HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
    ..We aimed to estimate the PAF and NNT of participants in the iPrEx (Pre-Exposure Prophylaxis Initiative) trial...
  8. pmc Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    Robert M Grant
    J David Gladstone Institutes, University of California at San Francisco, 1650 Owens St, San Francisco, CA 94158, USA
    N Engl J Med 363:2587-99. 2010
    ..Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition...
  9. pmc Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
    Marc M Solomon
    aThe Gladstone Institutes bUniversity of California cBridge HIV, San Francisco Department of Public Health, San Francisco, USA dInvestigaciones Medicas en Salud eAsociación Civil Impacta Salud y Educación, Lima, Peru fInstituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil gFenway Institute, Fenway Health, Boston, USA hResearch Institute for Health Sciences iDepartment of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand jProjeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil kDesmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa lDivision of Clinical Immunology and Allergy, School of Medicine, University of São Paulo mInstituto de Investigação em Imunologia, CEP 05403 900 Cerqueira Cesar, Sao Paulo, Brazil nNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    AIDS 28:851-9. 2014
    ..Tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis decreases sexual acquisition of HIV infection. We sought to evaluate the renal safety of TDF in HIV-uninfected persons...
  10. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013
    ..Fortunately, new strategies are being developed that could substantially reduce new infections globally, such as methods to increase adherence and the use of long-acting antiretroviral agents...
  11. pmc No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis
    Julia L Marcus
    Gladstone Institute of Virology and Immunology, San Francisco, California, United States of America University of California, Berkeley, California, United States of America
    PLoS ONE 8:e81997. 2013
    ..Self-reported sexual risk behavior decreased overall, but may be affected by reporting bias. We evaluated potential risk compensation using biomarkers of sexual risk behavior...
  12. ncbi request reprint Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men
    Albert Y Liu
    Department of Medicine, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 47:241-7. 2008
    ..Media reports have suggested substantial levels of community PrEP use despite its unproven effectiveness...
  13. ncbi request reprint CROI 2014: new tools to track the epidemic and prevent HIV infections
    Susan P Buchbinder
    University of California San Francisco, San Francisco, CA, USA
    Top Antivir Med 22:579-93. 2014
    ..As adherence is a crucial determinant of PrEP efficacy, long-acting PrEP agents are promising approaches being tested. ..